BEATHeartBeam, Inc.

Nasdaq heartbeam.com


$ 2.35 $ 0.04 (1.73 %)    

Monday, 09-Sep-2024 15:49:53 EDT
QQQ $ 455.25 $ 5.77 (1.29 %)
DIA $ 409.08 $ 4.58 (1.13 %)
SPY $ 546.60 $ 6.05 (1.12 %)
TLT $ 99.96 $ 0.43 (0.43 %)
GLD $ 231.58 $ 0.97 (0.42 %)
$ 2.35
$ 2.30 x 100
$ 2.36 x 100
-- - --
$ 1.06 - $ 3.39
28,440
na
62.42M
$ 0.34
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2024 06-30-2024 10-Q
2 05-09-2024 03-31-2024 10-Q
3 03-20-2024 12-31-2023 10-K
4 11-14-2023 09-30-2023 10-Q
5 08-10-2023 06-30-2023 10-Q
6 05-11-2023 03-31-2023 10-Q
7 03-16-2023 12-31-2022 10-K
8 11-10-2022 09-30-2022 10-Q
9 08-11-2022 06-30-2022 10-Q
10 05-12-2022 03-31-2022 10-Q
11 03-24-2022 12-31-2021 10-K
12 12-16-2021 09-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 benchmark-reiterates-speculative-buy-on-heartbeam-maintains-8-price-target

Benchmark analyst Bill Sutherland reiterates HeartBeam (NASDAQ:BEAT) with a Speculative Buy and maintains $8 price target.

 heartbeam-q2-2024-gaap-eps-019-misses-017-estimate

HeartBeam (NASDAQ:BEAT) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.17) b...

 heartbeam-added-to-russell-microcap-index

HeartBeam, Inc. (NASDAQ:BEAT), a medical technology company focused on transforming cardiac care through the power of personali...

 heartbeams-study-demonstrates-ai-algorithm-combined-with-vectorcardiography-outperforms-panel-of-cardiologists-in-detecting-arrhythmias

New Data Presented at Heart Rhythm Society Conference Demonstrates Continued Progress with Company's AI ProgramData Show Th...

 benchmark-reiterates-speculative-buy-on-heartbeam-maintains-8-price-target

Benchmark analyst Bill Sutherland reiterates HeartBeam (NASDAQ:BEAT) with a Speculative Buy and maintains $8 price target.

 heartbeam-q1-2024-gaap-eps-017-misses-015-estimate

HeartBeam (NASDAQ:BEAT) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.15) b...

 heartbeam-presents-results-on-ai-capabilities-for-detecting-arrhythmias

New Data Presented at the European Heart Rhythm Association Conference Marks First Scientific Presentation on HeartBeam AI, the...

 benchmark-reiterates-speculative-buy-on-heartbeam-maintains-8-price-target

Benchmark analyst Bill Sutherland reiterates HeartBeam (NASDAQ:BEAT) with a Speculative Buy and maintains $8 price target.

 why-fedex-shares-are-trading-higher-by-around-12-here-are-20-stocks-moving-premarket

Shares of FedEx Corporation (NYSE: FDX) rose sharply in today’s pre-market trading after the company reported better-than-expe...

 recap-heartbeam-q4-earnings
Recap: HeartBeam Q4 Earnings
03/20/2024 20:15:08

 heartbeam-q4-2023-gaap-eps-013-inline

HeartBeam (NASDAQ:BEAT) reported quarterly losses of $(0.13) per share which met the analyst consensus estimate.

 earnings-scheduled-for-march-20-2024

Companies Reporting Before The Bell • UP Fintech Holding (NASDAQ:TIGR) is expected to report quarterly earnings at $0.07 per s...

 a-preview-of-heartbeams-earnings
A Preview Of HeartBeam's Earnings
03/19/2024 15:02:08

 whats-going-on-with-heartbeam-beat-stock

Heartbeam shares are trading higher by 3.5% to $2.35 Tuesday, pulling back following the session high of $2.70. The company la...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION